目录肽产品
AMYD-003B
β-Amyloid (1-42), TFA
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala TFA salt
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala TFA salt
Size：1.0
P1(RMB)：1195
MW：4514.1
One letter sequence：DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA \nTFA salt
Molecular Formula：C203H311N55O60S1
Description：42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
Literature Reference：Neurobiology of Aging, 13, No.5 (1992)
Cas：
P1(RMB)：1195
MW：4514.1
One letter sequence：DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA \nTFA salt
Molecular Formula：C203H311N55O60S1
Description：42-residue peptide believed to be the major subunit of the vascular and plaque filaments in individuals with Alzheimer's disease, elderly people and patients with Trisomy 21 (Down's Syndrome). Inactive control.
Literature Reference：Neurobiology of Aging, 13, No.5 (1992)
Cas：
